rewirebio.iobenchmarks
Dataset

UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)

Trio cases with an initial P/LP or VUS finding, used as positive controls for Talos.

Evaluation results

2 evaluations · 8 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Talos 8.2.0 on archived DRAGEN v3.7.5 VCFs, pedigree where available (Kaschta et al. 2026)Protocol: Talos recovery of known P/LP and VUS variants in 162 trio cases (Kaschta et al. 2026)
Dataset: UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)
6.2% Proportion (known P/LP variants missed: pipeline conversion errors)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Talos in trio mode on 162 trio benchmarking cases

reanalysis-kaschta-20261010-protocol-talos-trio-benchmark

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Benchmarking of Automated Reanalysis: Trio Cases P1, 'nine pipeline conversion errors (6.2%)'
Configuration: Talos 8.2.0 on archived DRAGEN v3.7.5 VCFs, pedigree where available (Kaschta et al. 2026)Protocol: Talos recovery of known P/LP and VUS variants in 162 trio cases (Kaschta et al. 2026)
Dataset: UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)
6.2% Proportion (known P/LP variants missed: HPO annotation gaps)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Talos in trio mode on 162 trio benchmarking cases

reanalysis-kaschta-20261010-protocol-talos-trio-benchmark

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Benchmarking of Automated Reanalysis: Trio Cases P1, 'nine HPO annotation gaps (6.2%)'
Configuration: Talos 8.2.0 on archived DRAGEN v3.7.5 VCFs, pedigree where available (Kaschta et al. 2026)Protocol: Talos recovery of known P/LP and VUS variants in 162 trio cases (Kaschta et al. 2026)
Dataset: UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)
7.6% Proportion (known P/LP variants not prioritised because of trio inheritance filtering)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Talos in trio mode on 162 trio benchmarking cases

reanalysis-kaschta-20261010-protocol-talos-trio-benchmark

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Benchmarking of Automated Reanalysis: Trio Cases P2, 'An additional 11 P/LP variants (7.6%) were not prioritized'
Configuration: Talos 8.2.0 on archived DRAGEN v3.7.5 VCFs, pedigree where available (Kaschta et al. 2026)Protocol: Talos recovery of known P/LP and VUS variants in 162 trio cases (Kaschta et al. 2026)
Dataset: UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)
2.1% Proportion (known P/LP variants missed: large copy-number variants not processed)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Talos in trio mode on 162 trio benchmarking cases

reanalysis-kaschta-20261010-protocol-talos-trio-benchmark

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Benchmarking of Automated Reanalysis: Trio Cases P1, 'three large copy-number variants not processed by the pipeline (2.1%)'
Configuration: Talos 8.2.0 on archived DRAGEN v3.7.5 VCFs, pedigree where available (Kaschta et al. 2026)Protocol: Talos recovery of known P/LP and VUS variants in 162 trio cases (Kaschta et al. 2026)
Dataset: UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)
2.8% Proportion (known P/LP variants missed: out-of-scope variant classes)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Talos in trio mode on 162 trio benchmarking cases

reanalysis-kaschta-20261010-protocol-talos-trio-benchmark

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Benchmarking of Automated Reanalysis: Trio Cases P1, 'four out-of-scope variant classes (2.8%)'
Configuration: Talos 8.2.0 on archived DRAGEN v3.7.5 VCFs, pedigree where available (Kaschta et al. 2026)Protocol: Talos recovery of known P/LP and VUS variants in 162 trio cases (Kaschta et al. 2026)
Dataset: UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)
75.2% Recall (known P/LP variants prioritised, trio mode)
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Talos in trio mode on 162 trio benchmarking cases

reanalysis-kaschta-20261010-protocol-talos-trio-benchmark

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Benchmarking of Automated Reanalysis: Trio Cases P1, 'overall P/LP concordance of 75.2%'
Configuration: Talos 8.2.0, proband-only mode on trio cases (Kaschta et al. 2026)Protocol: Talos recovery of known P/LP and VUS variants in 162 trio cases (Kaschta et al. 2026)
Dataset: UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)
82.8% Recall (known P/LP variants prioritised, proband-only mode)
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Talos in proband-only mode on 162 trio benchmarking cases

reanalysis-kaschta-20261010-protocol-talos-trio-benchmark

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Benchmarking of Automated Reanalysis: Trio Cases P3, 'increasing concordance to 82.8%'
Configuration: Talos 8.2.0 on archived DRAGEN v3.7.5 VCFs, pedigree where available (Kaschta et al. 2026)Protocol: Talos recovery of known P/LP and VUS variants in 162 trio cases (Kaschta et al. 2026)
Dataset: UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)
Six Count (known VUS prioritised, trio mode)
count · unknown

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Talos in trio mode on 162 trio benchmarking cases

reanalysis-kaschta-20261010-protocol-talos-trio-benchmark

Aggregation: Not reported

Automated versus manual reanalysis in rare disease genomics · Results, Benchmarking of Automated Reanalysis: Trio Cases P1, 'Six VUS variants were captured'

Source checking is not independent reproduction. Release 2026-10-10-cbb3da59bc08.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-10-10-cbb3da59bc08 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

7 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-10-cbb3da59bc08
Property and statementOriginal source and locationReview and provenance
Patient count
162
Context-only references
Automated versus manual reanalysis in rare disease genomics

Original source ↗

Results 'Benchmarking of Automated Reanalysis: Trio Cases' P1

Version: medRxiv 2026.05.16.26352295 v1, posted 2026-05-19; JATS source XML
Retrieved: 2026-10-10T06:04:35Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.patient_count

Source artifact SHA-256: db4ed16a501eda14ba114f8693f39596b03d7afaeafa8adafa41d84d9a61f6bd

Hash scope: SHA-256 of the JATS source XML as returned on 2026-10-10.

Inspected artifact

Population
129 cases with 145 P/LP variants and 33 cases with 43 VUS. Methods 'Benchmarking of Automated Reanalysis' P1 gives 34 trio cases with VUS variants; Methods 'Study Cohort and Reanalysis Design' P2 and Results 'Trio Cases' P1 give 33, which is used here
Context-only references
Automated versus manual reanalysis in rare disease genomics

Original source ↗

Results 'Benchmarking of Automated Reanalysis: Trio Cases' P1

Version: medRxiv 2026.05.16.26352295 v1, posted 2026-05-19; JATS source XML
Retrieved: 2026-10-10T06:04:35Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: db4ed16a501eda14ba114f8693f39596b03d7afaeafa8adafa41d84d9a61f6bd

Hash scope: SHA-256 of the JATS source XML as returned on 2026-10-10.

Inspected artifact

Source location
Results 'Benchmarking of Automated Reanalysis: Trio Cases' P1
Context-only references
Automated versus manual reanalysis in rare disease genomics

Original source ↗

Results 'Benchmarking of Automated Reanalysis: Trio Cases' P1

Version: medRxiv 2026.05.16.26352295 v1, posted 2026-05-19; JATS source XML
Retrieved: 2026-10-10T06:04:35Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: db4ed16a501eda14ba114f8693f39596b03d7afaeafa8adafa41d84d9a61f6bd

Hash scope: SHA-256 of the JATS source XML as returned on 2026-10-10.

Inspected artifact

Split
No split
Context-only references
Automated versus manual reanalysis in rare disease genomics

Original source ↗

Results 'Benchmarking of Automated Reanalysis: Trio Cases' P1

Version: medRxiv 2026.05.16.26352295 v1, posted 2026-05-19; JATS source XML
Retrieved: 2026-10-10T06:04:35Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: db4ed16a501eda14ba114f8693f39596b03d7afaeafa8adafa41d84d9a61f6bd

Hash scope: SHA-256 of the JATS source XML as returned on 2026-10-10.

Inspected artifact

Version
As published (v1)
Context-only references
Automated versus manual reanalysis in rare disease genomics

Original source ↗

Results 'Benchmarking of Automated Reanalysis: Trio Cases' P1

Version: medRxiv 2026.05.16.26352295 v1, posted 2026-05-19; JATS source XML
Retrieved: 2026-10-10T06:04:35Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: db4ed16a501eda14ba114f8693f39596b03d7afaeafa8adafa41d84d9a61f6bd

Hash scope: SHA-256 of the JATS source XML as returned on 2026-10-10.

Inspected artifact

Description
Trio cases with an initial P/LP or VUS finding, used as positive controls for Talos.
Context-only references
Automated versus manual reanalysis in rare disease genomics

Original source ↗

Results 'Benchmarking of Automated Reanalysis: Trio Cases' P1

Version: medRxiv 2026.05.16.26352295 v1, posted 2026-05-19; JATS source XML
Retrieved: 2026-10-10T06:04:35Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: db4ed16a501eda14ba114f8693f39596b03d7afaeafa8adafa41d84d9a61f6bd

Hash scope: SHA-256 of the JATS source XML as returned on 2026-10-10.

Inspected artifact

Name
UKSH trio benchmarking cases with known findings (Kaschta et al. 2026)
Context-only references
Automated versus manual reanalysis in rare disease genomics

Original source ↗

Results 'Benchmarking of Automated Reanalysis: Trio Cases' P1

Version: medRxiv 2026.05.16.26352295 v1, posted 2026-05-19; JATS source XML
Retrieved: 2026-10-10T06:04:35Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: db4ed16a501eda14ba114f8693f39596b03d7afaeafa8adafa41d84d9a61f6bd

Hash scope: SHA-256 of the JATS source XML as returned on 2026-10-10.

Inspected artifact

Sources and history

Release 2026-10-10-cbb3da59bc08 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: reanalysis-kaschta-20261010-data-uksh-trio-benchmark

areas
dna-genomes
contexts
clinical_research
version
As published (v1)
patient count
162
population
129 cases with 145 P/LP variants and 33 cases with 43 VUS. Methods 'Benchmarking of Automated Reanalysis' P1 gives 34 trio cases with VUS variants; Methods 'Study Cohort and Reanalysis Design' P2 and Results 'Trio Cases' P1 give 33, which is used here
split
No split
source locator
Results 'Benchmarking of Automated Reanalysis: Trio Cases' P1
Related records

Suggest a correction